Tag: Gene therapy

Non-viral vector for gene therapy in inherited retinal degeneration

Authors: Wei Xing,  Sui Ruifang DOI: 10.3760/cma.j.cn115989-20200627-00457 Published 2021-08-10 Cite asChin J Exp Ophthalmol, 2021, 39(8): 737-742. Abstract                              [View PDF] [Read Full Text] Inherited retinal degeneration (IRD), a group of diseases often causing irreversible blindness, with multiple pathogenesis, still lacks effective treatments currently.Development of effective […]

Related clinical trials and prospects of gene therapy for neovascular age-related macular degeneration

Authors: Zhang Wei,  Yan Hua DOI: 10.3760/cma.j.cn115989-20210113-00033 Published 2021-08-10 Cite asChin J Exp Ophthalmol, 2021, 39(8): 749-754. Abstract                              [View PDF] [Read Full Text] Neovascular macular degeneration (nAMD) is one of the main eye diseases causing blindness in the elderly population.Early detection and early treatment are […]

Gene therapy for retinal diseases: global progress and challenges

Author: Wu Zhijian DOI: 10.3760/cma.j.cn115989-20200716-00500 Published 2020-08-10 Cite as Chin J Exp Ophthalmol, 2020,38(08): 633-638. Abstract                              [View PDF] [Read Full Text] In the past three decades, we have witnessed the great promise of gene therapy in treating a variety of inherited and acquired retinal diseases. The […]

Advances of genetics of age-related macular degeneration

Authors: Xu Jingjing,  Hu Yuntao DOI: 10.3760/cma.j.cn115989-20200509-00324 Published 2020-08-10 Cite as Chin J Exp Ophthalmol, 2020,38(08): 715-720. Abstract                              [View PDF] [Read Full Text] Age-related macular degeneration (AMD) is one of the leading causes of blindness for the elderly over 50, characterized by loss of central vision […]

Tropisms of rAAV2, 6, 8, 9 serotypes for intravitreal injection in the mouse retina

Authors: Li Taiming,  Wei Zheng,  Liu Xiaomei,  Shao Jiahong,  Yuan Yun,  Cao Jinjing,  Wang Feifei,  Wang Dongxin,  Li Wensheng,  Zhang Chun DOI: 10.3760/cma.j.cn115989-20200326-00210 Published 2020-05-10 Cite as Chin J Exp Ophthalmol, 2020,38(05): 381-387. Abstract                               [View PDF] [Read Full Text] Objective To compare the tropism of different […]

Focus on the treatment of inherited retinal diseases

Author:Pang Jijing DOI: 10.3760/cma.j.issn.2095-0160.2019.09.001 Published 2019-09-10 Cite as Chin J Exp Ophthalmol, 2019,37(9): 689-693. Abstract                              [View PDF] [Read Full Text] Inherited retinal diseases (IRDs) are rare and incurable eye diseases.Gene therapy has become a new method for the treatment of IRDs.At present, at least 26 clinical […]

Advance in gene therapy of ocular disease

Authors:Lyu Juling,  Xing Yiqiao,  Shen Yin DOI: 10.3760/cma.j.issn.2095-0160.2016.10.019 Published 2016-10-10 Cite as Chin J Exp Ophthalmol, 2016,34(10): 952-956. Abstract                              [Download PDF] [Read Full Text] Currently, 31 clinical trials have been approved, most of them are still in progress.Leber congenital amaurosis (LCA) has been conducted to phase […]

Research progress in neuroregeneration of traumatic optic neuropathy

Authors: Chen Haiying,  Huang Zhengru DOI: 10.3760/cma.j.issn.2095-0160.2018.01.016 Published 2018-01-10 Cite as Chin J Exp Ophthalmol, 2018,36(1): 75-80. Abstract                              [Download PDF] [Read Full Text] Traumatic optic neuropathy (TON) is commonly associated with blunt ocular trauma and craniofacial injuries, leading irreversible visual impairment.Like other mammalian […]

Application of CRISPR/Cas9 genome editing technology in the research of eye diseases

Authors:  Fan Xiangyu,  Xu Jianjiang DOI: 10.3760/cma.j.issn.2095-0160.2018.07.015 Published 2018-07-10 Cite as Chin J Exp Ophthalmol, 2018,36(7): 553-558. Abstract                               [Download PDF] [Read Full Text] The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) is an adaptive immune system against invasive viruses and exogenous DNA, which is developed […]

Studies on pathogenesis and gene therapy of red-green color blindness

Authors:  Xu Fan,  Pang Jijing DOI: 10.3760/cma.j.issn.2095-0160.2018.07.014 Published 2018-07-10 Cite as Chin J Exp Ophthalmol, 2018,36(7): 549-552. Abstract                               [Download PDF] [Read Full Text] Red-green color blindness is the most common form of colour blindness.Traditional treatment options such as tinted lenses do not cure color blindness completely.With the […]